샘플 요청 목록

 카트 문의
시장보고서
상품코드
1528048

세계의 전기 의료 및 생체 전기 의료 시장

Electroceuticals / Bioelectric Medicine
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 277 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전기 의료 및 생체 전기 의료 시장은 2030년까지 284억 달러에 이를 것으로 예상됩니다.

2023년에 185억 달러로 추정된 전기 의료 및 생체 전기 의료의 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 6.3%로 성장하여 2030년에는 284억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 심장 페이스메이커 & ICD는 복합 연간 성장률(CAGR) 7.1%로 성장을 지속하여 분석 기간이 끝날 때까지 179억 달러에 달할 것으로 예측됩니다. 인공 내이 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 5.3%로 추정됩니다.

미국 시장은 77억 달러, 중국은 복합 연간 성장률(CAGR) 7.2%로 성장할 것으로 예측됩니다.

미국 전기 의료 및 생체 전기 의료 시장은 2023년에 77억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 23억 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR)은 7.2%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 5.6%와 6.1%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 약 6.1%로 성장할 것으로 예측됩니다.

세계의 전기 의료/생체 전기 의료 시장 - 주요 동향과 촉진요인 요약

전기 의료란 무엇이며, 어떻게 의료를 변혁하는가?

전기 제제는 생체 전기 의약품으로도 알려져 있으며, 전기 임펄스를 사용하여 신체의 신경계를 조절하고 다양한 질병을 치료하는 데 중점을 둔 의학의 최첨단 분야입니다. 화학물질을 이용하여 생물학적 반응을 일으키는 종래의 의약품과 달리, 전기치료제는 표적을 좁힌 전기자극을 이용하여 신경활동을 조절하여 장기기능에 영향을 주고 치료효과를 가져옵니다. 이 접근법은 일종의 만성 통증 증후군, 심부전, 심지어 정신 질환과 같은 전통적인 의약품에 내성을 나타내는 질병과 증상의 치료에 사용할 수 있습니다. 전기 의료의 원리는 뇌와 다양한 기관을 연결하는 신경의 복잡한 네트워크에 있습니다. 이러한 신경 신호를 정확하게 조정함으로써 의사는 생체 전기의 출처에서 직접 이상을 수정하는 것을 목표로합니다.

기술은 어떻게 전기 의료 응용을 진보시키고 있는가?

마이크로 일렉트로닉스와 생명공학의 발전은 전기치료 분야를 전진시키는 데 매우 중요합니다. 신경 매핑의 최신 기술과 신체의 표적 부위에 정확한 전기 임펄스를 보낼 수있는 소형의 임베디드 장치의 개발로이 기술의 응용 가능성은 크게 확산되고 있습니다. 이러한 장치는 종종 웨어러블 또는 외부 컨트롤러에 연결되어 환자 고유의 요구에 맞게 실시간으로 치료를 조정할 수 있습니다. 이 정확도의 높이는 치료 효과를 향상시킬뿐만 아니라 약물과 같은 전신 치료에 흔한 부작용을 최소화합니다. 또한, 현재 진행중인 생체 전기 신호 전달과 신경 인터페이스의 연구는 더욱 정교한 질병 치료법이 개발될 것으로 기대되며, 만성 질환 관리에 혁명을 가져오고, 약리학적 개입에 대한 의존을 줄일 수 있습니다.

현재의 치료에 있어서, 전기 제제는 어떤 역할을 하고 있는가?

현재, 전기 제제는 다양한 의료 장면에서 응용되고 있으며, 특히 통증, 신경 장애, 심장 질환의 관리에 응용되고 있습니다. 예를 들어, 척수 자극 장치는 약제로 치료가 불충분하거나 부적절한 환자의 만성 통증을 크게 완화시킬 수 있습니다. 유사하게, 뇌 심부 자극기는 파킨슨 병 증상의 치료에 유망하며, 이환자의 삶의 질을 크게 향상시킵니다. 심장병학에서는 심박조율기와 이식형 제세동기(ICD)가 비정상적인 심장 리듬을 수정하여 심부전과 심장 돌연사를 예방합니다. 이러한 다양한 증상의 치료에서 전기 제제의 다용도는 특히 기술이 향상되고 신경계에서 새로운 치료 표적이 발견됨에 따라 전기 제제가 미래의 의료 현장에서 주력이 될 가능성을 강조하고 있습니다.

전기 의료 시장의 성장을 가속할 것은 무엇인가?

전기 의료 시장의 성장은 기술 혁신, 세계 인구의 고령화, 만성 질환의 부담 증가 등 여러 요인에 의해 초래됩니다. 생물 의학 연구가 보다 정교하고 소형화된 장비를 제공함에 따라 전기 제형의 적용 범위가 확대되고 임상 의사는 보다 광범위한 증상과 더 높은 효능으로 대처할 수 있습니다. 세계 노인 인구 역학의 변화로 인해 심혈관 장애와 신경 질환과 같은 전기 의료에 적합한 만성 질환의 유병률이 높아지고 있습니다. 게다가, 건강 관리 비용 증가, 특히 의약품의 장기적인 사용으로 인해, 종종 전기 의료는 비용 효율적인 대안이 되었습니다. 소비자의 행동도 변화하고 있으며, 부작용이 적고 약물을 섭취하지 않는 치료를 선호하는 경향이 강해지고 있습니다.

조사 대상 기업 예(전 50건)

  • Abbott Laboratories, Inc.
  • Medtronic PLC
  • Cochlear Ltd.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • MicroPort Scientific Corporation
  • BioElectronics Corporation
  • Beijing Pins Medical Co., Ltd.
  • Neuronetics, Inc.
  • Endonovo Therapeutics, Inc.
  • Axonics Modulation Technologies, Inc.
  • CEFALY-Technology
  • Nu Eyne Company Limited
  • Gimer Medical
  • Bioinduction

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

BJH

Global Electroceuticals / Bioelectric Medicine Market to Reach US$28.4 Billion by 2030

The global market for Electroceuticals / Bioelectric Medicine estimated at US$18.5 Billion in the year 2023, is expected to reach US$28.4 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2023-2030. Cardiac Pacemakers & ICDs, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$17.9 Billion by the end of the analysis period. Growth in the Cochlear Implants segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.7 Billion While China is Forecast to Grow at 7.2% CAGR

The Electroceuticals / Bioelectric Medicine market in the U.S. is estimated at US$7.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.6% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Electroceuticals/Bioelectric Medicine Market - Key Trends & Drivers Summarized

What Are Electroceuticals and How Are They Transforming Medicine?

Electroceuticals, also known as bioelectric medicines, represent a cutting-edge field in medical science that focuses on using electrical impulses to modulate the body's nervous system to treat a variety of ailments. Unlike traditional pharmaceuticals that use chemicals to provoke a biological response, electroceuticals employ targeted electrical stimulation to modulate nerve activity, influencing organ function and offering therapeutic benefits. This approach can be used to treat diseases and conditions that have been resistant to conventional medicines, such as certain chronic pain syndromes, heart failure, and even mental health disorders. The principle behind electroceuticals lies in the intricate network of nerves that link the brain to different organs; by precisely adjusting these nerve signals, doctors aim to correct abnormalities directly at their bioelectrical source.

How Is Technology Advancing Electroceutical Applications?

The advancements in microelectronics and biotechnology have been pivotal in propelling the field of electroceuticals forward. Modern techniques in neural mapping and the development of miniature, implantable devices capable of delivering precise electrical impulses to targeted areas within the body have significantly broadened the potential applications of this technology. These devices are often connected to wearable or external controllers that allow for real-time adjustments in therapy, tailored to patient-specific needs. This level of precision not only enhances the effectiveness of treatment but also minimizes side effects commonly associated with more systemic treatments like drugs. Additionally, ongoing research in bioelectrical signaling and neural interfaces promises to unlock even more sophisticated methods of treating diseases, potentially revolutionizing the management of chronic conditions and reducing dependence on pharmacological interventions.

What Role Does Electroceuticals Play in Current Medical Treatments?

Currently, electroceuticals are being applied in a variety of medical contexts, most notably in the management of pain, neurological disorders, and cardiac issues. For example, spinal cord stimulators can significantly alleviate chronic pain in patients for whom pharmaceutical treatments are insufficient or inappropriate. Similarly, deep brain stimulators have shown promise in treating Parkinson’s disease symptoms, substantially improving life quality for affected individuals. In cardiology, devices like pacemakers and implantable cardioverter-defibrillators (ICDs) correct abnormal heart rhythms, crucially preventing heart failure and sudden cardiac death. The versatility of electroceuticals in treating such diverse conditions underscores their potential to be a mainstay in future medical practices, particularly as technologies improve and new therapeutic targets within the nervous system are discovered.

What Drives the Growth in the Electroceuticals Market?

The growth in the electroceuticals market is driven by several factors, including technological innovations, an aging global population, and an increasing burden of chronic diseases. As biomedical research delivers more sophisticated and miniaturized devices, the applicability of electroceuticals expands, allowing clinicians to address a broader range of conditions with greater efficacy. The demographic shift towards an older population worldwide leads to a higher prevalence of chronic diseases, such as cardiovascular disorders and neurological conditions, which are well-suited for electroceutical interventions. Furthermore, the rising cost of healthcare, particularly the long-term use of pharmaceuticals, makes electroceuticals a cost-effective alternative in many cases. Consumer behavior is also shifting; there is a growing preference for treatments that have fewer side effects and do not involve drug intake, which often aligns well with electroceutical solutions.

Select Competitors (Total 50 Featured) -

  • Abbott Laboratories, Inc.
  • Medtronic PLC
  • Cochlear Ltd.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • MicroPort Scientific Corporation
  • BioElectronics Corporation
  • Beijing Pins Medical Co., Ltd.
  • Neuronetics, Inc.
  • Endonovo Therapeutics, Inc.
  • Axonics Modulation Technologies, Inc.
  • CEFALY-Technology
  • Nu Eyne Company Limited
  • Gimer Medical
  • Bioinduction

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Electroceuticals / Bioelectric Medicine - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • An Introduction to Electroceuticals/Bioelectric Medicine
    • Using Electrical Stimulation in Nerves: Historical Perspective
    • Types of Electroceutical Devices
    • Major Applications of Electroceuticals/Bioelectric Medicine
    • Global Market Prospects & Outlook
    • Implantable Electroceutical Devices: The Leading Category
    • Cardiac Pacemakers & Implantable Cardioverter Defibrillators Segment Lead the Global Market
    • Developed Regions Lead, Developing Economies to Spearhead Growth
    • Competition
    • Global DBS Market Share Breakdown of Revenues by Leading Players: 2020E
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Electroceutical/Biomedical Medicine Emerges to Overcome Drawbacks of Traditional Treatments
    • Faster Healing: A Key Benefit Fueling Growth in Electroceuticals Market
    • Ineffectiveness of Drug Therapy and Issues with Side Effects Present Opportunities for Electroceuticals Market
    • Disease-specific Electroceuticals to Drive Future Gains
    • Aging Global Population Raises Risk of Neurological & Cardiovascular Diseases, Fueling Market Outlook
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Growing Prevalence of Cardiovascular Diseases and Need for Effective Treatments Supports Market Growth
    • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
    • Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
    • Cardiac Pacemaker: A Solution for Cardiac Arrythmias
    • Transcatheter Cardiac Pacemakers: Benefits Fuel Market Growth
    • Technological Advancements to Transform Cardiac Pacemaker Devices Marketplace
    • Rising Incidence of Neurological Disorders and Need for Novel Therapies to Spur Market Growth
    • Annual Incidence of Adult-Onset Neurologic Disorders in the US
    • Bioelectronic Medicine Emerges as a Vital Therapy for Targeted Neuromodulation
    • Deep Brain Stimulators: Useful in Treatment of Neurodegenerative Diseases
    • Global Alzheimer's Prevalence by Age Group
    • Diagnosed Prevalence Cases of Parkinson's Disease in Select Countries
    • Select Available Deep Brain Stimulation Devices Available in the Market
    • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
    • Developments in Vagal Nerve Stimulation (VNS) Devices
    • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
    • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
    • Biodegradable Devices For Nerve Recovery
    • Bioelectric Medicine: A Potential Treatment Approach for Crohn's Disease
    • Growing Prevalence of Hearing Loss Boosts Opportunities in the Cochlear Implants Market
    • Global Prevalence (%) by Severity of Hearing Loss
    • Vendors Focus on Innovations in Cochlear Implants
    • Developing Economies to Boost Long-term Prospects
    • Electroceutical Acupuncture: Emerging Pain Therapy
    • Neuropuncture - The Electroceutical Technology to Treat Pain & Injury
    • Bioelectronics Technology Fuels Advances in Next-Generation of Device Therapeutics
    • Market Benefits from the Significant Advantages of Bioelectronics
    • Overcoming the Challenges
    • Increasing Research Activity in Bioelectric Medicine Drives Market Opportunities
    • Market Poised to Benefit from the Development of New Bioelectronic Devices
    • Technological Advancements to Boost Growth Prospects
    • Rise in Healthcare Expenditure to Drive Growth
    • Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiac Pacemakers & ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cardiac Pacemakers & ICDs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cochlear Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Cochlear Implants by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Spinal Cord Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Spinal Cord Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Deep Brain Stimulators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Deep Brain Stimulators by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Clinics & ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals, Clinics & ASCs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Electroceuticals / Bioelectric Medicine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Electroceuticals / Bioelectric Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by Product - Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by Product - Percentage Breakdown of Value Revenues for Cardiac Pacemakers & ICDs, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators and Other Products for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Electroceuticals / Bioelectric Medicine by End-Use - Hospitals, Clinics & ASCs and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Electroceuticals / Bioelectric Medicine by End-Use - Percentage Breakdown of Value Revenues for Hospitals, Clinics & ASCs and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제